trending Market Intelligence /marketintelligence/en/news-insights/trending/ta-PAzAmuK4-gzcCwBozOg2 content esgSubNav
In This List

Takeda's $62B acquisition of Shire gets approval of Jersey court

Blog

Highlighting the Top Regional Aftermarket Research Brokers by Sector Coverage

Blog

Insight Weekly: PE firms shift strategies; bank earnings kick off; bankruptcies plummet

Blog

Insight Weekly: Stocks limp into 2023; GCC banks set for rebound; deep-sea mining faces pushback

Blog

Infographic: The Big Picture 2023 Issuer & Investor Relations Outlook


Takeda's $62B acquisition of Shire gets approval of Jersey court

Takeda Pharmaceutical Co. Ltd. said the Royal Court of Jersey approved its $62 billion acquisition of Irish drugmaker Shire PLC.

The Japanese drugmaker, which finally managed to claim Shire in its fifth takeover attempt in May 2018, said the acquisition is expected to close Jan. 8.

The deal has already been approved by the shareholders of both companies, the EU and the Japan Fair Trade Commission.